Suppr超能文献

超越自由基清除作用:依达拉奉(Radicut)在多种疾病中的有益作用(综述)

Beyond free radical scavenging: Beneficial effects of edaravone (Radicut) in various diseases (Review).

作者信息

Kikuchi Kiyoshi, Takeshige Nobuyuki, Miura Naoki, Morimoto Yoko, Ito Takashi, Tancharoen Salunya, Miyata Kei, Kikuchi Chiemi, Iida Narumi, Uchikado Hisaaki, Miyagi Naohisa, Shiomi Naoto, Kuramoto Terukazu, Maruyama Ikuro, Morioka Motohiro, Kawahara Ko-Ichi

机构信息

Department of Neurosurgery, Yame Public General Hospital, Yame 834-0034;

出版信息

Exp Ther Med. 2012 Jan;3(1):3-8. doi: 10.3892/etm.2011.352. Epub 2011 Sep 20.

Abstract

Free radicals play an important role in the pathogenesis of a variety of diseases; thus, they are an attractive target for therapeutic intervention in these diseases. Compounds capable of scavenging free radicals have been developed for this purpose and some, developed for the treatment of cerebral ischemic stroke, have progressed to clinical trials. One such scavenger, edaravone, is used to treat patients within 24 h of stroke. Edaravone, which can diffuse into many disease-affected organs, also shows protective effects in the heart, lung, intestine, liver, pancreas, kidney, bladder and testis. As well as scavenging free radicals, edaravone has anti-apoptotic, anti-necrotic and anti-cytokine effects in various diseases. Here, we critically review the literature on its clinical efficacy and examine whether edaravone should be considered a candidate for worldwide development, focusing on its effects on diseases other than cerebral infarction. Edaravone has been safely used as a free radical scavenger for more than 10 years; we propose that edaravone may offer a novel treatment option for several diseases.

摘要

自由基在多种疾病的发病机制中起着重要作用;因此,它们是这些疾病治疗干预的一个有吸引力的靶点。为此,已经开发出了能够清除自由基的化合物,其中一些用于治疗脑缺血性中风的化合物已经进入临床试验阶段。一种这样的清除剂依达拉奉,用于在中风后24小时内治疗患者。依达拉奉能够扩散到许多受疾病影响的器官,在心脏、肺、肠道、肝脏、胰腺、肾脏、膀胱和睾丸中也显示出保护作用。除了清除自由基外,依达拉奉在各种疾病中还具有抗凋亡、抗坏死和抗细胞因子的作用。在此,我们批判性地回顾了关于其临床疗效的文献,并探讨依达拉奉是否应被视为全球开发的候选药物,重点关注其对脑梗死以外疾病的影响。依达拉奉作为自由基清除剂已安全使用了10多年;我们认为依达拉奉可能为几种疾病提供一种新的治疗选择。

相似文献

1
Beyond free radical scavenging: Beneficial effects of edaravone (Radicut) in various diseases (Review).
Exp Ther Med. 2012 Jan;3(1):3-8. doi: 10.3892/etm.2011.352. Epub 2011 Sep 20.
2
The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease.
Int J Mol Sci. 2013 Jul 4;14(7):13909-30. doi: 10.3390/ijms140713909.
3
Beyond neurological disease: new targets for edaravone (Review).
Int J Mol Med. 2011 Dec;28(6):899-906. doi: 10.3892/ijmm.2011.795. Epub 2011 Sep 15.
4
Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction.
Exp Ther Med. 2011 Sep;2(5):771-775. doi: 10.3892/etm.2011.281. Epub 2011 Jun 7.
6
[Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent].
Nihon Yakurigaku Zasshi. 2002 May;119(5):301-8. doi: 10.1254/fpj.119.301.
7
A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?
Expert Opin Pharmacother. 2010 Jul;11(10):1753-63. doi: 10.1517/14656566.2010.493558.
8
[Research and development of the free radical scavenger edaravone as a neuroprotectant].
Yakugaku Zasshi. 2004 Mar;124(3):99-111. doi: 10.1248/yakushi.124.99.
9
How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?
J Clin Biochem Nutr. 2018 Jan;62(1):20-38. doi: 10.3164/jcbn.17-62. Epub 2017 Nov 11.
10
Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.
Kidney Int. 2004 May;65(5):1714-23. doi: 10.1111/j.1523-1755.2004.00567.x.

引用本文的文献

3
The protective effect of Edaravone against acute renocardiac syndrome in a kidney ischemia-reperfusion model.
J Cardiovasc Thorac Res. 2024;16(4):243-248. doi: 10.34172/jcvtr.33077. Epub 2024 Dec 23.
5
Ameliorative effects of Edaravone against Valproic Acid-Induced kidney damage.
J Mol Histol. 2024 Nov 27;56(1):4. doi: 10.1007/s10735-024-10291-5.
6
Sorafenib and edaravone protect against renal fibrosis induced by unilateral ureteral obstruction via inhibition of oxidative stress, inflammation, and RIPK-3/MLKL pathway.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8961-8977. doi: 10.1007/s00210-024-03146-z. Epub 2024 Jun 14.
7
Antiviral Effect and Mechanism of Edaravone against Grouper Iridovirus Infection.
Viruses. 2023 Nov 10;15(11):2237. doi: 10.3390/v15112237.
8
Synthesis of 4-Aminopyrazol-5-ols as Edaravone Analogs and Their Antioxidant Activity.
Molecules. 2022 Nov 9;27(22):7722. doi: 10.3390/molecules27227722.
9
Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trial.
Inflammopharmacology. 2022 Aug;30(4):1277-1282. doi: 10.1007/s10787-022-01001-2. Epub 2022 Jun 20.
10
Adjunctive cytoprotective therapies in acute ischemic stroke: a systematic review.
Fluids Barriers CNS. 2021 Oct 19;18(1):46. doi: 10.1186/s12987-021-00280-1.

本文引用的文献

1
Edaravone, a free radical scavenger, promotes engraftment of intraportally transplanted islet cells.
Pancreas. 2011 Jan;40(1):126-30. doi: 10.1097/MPA.0b013e3181f7e436.
3
Edaravone, a known free radical scavenger, enhances X-ray-induced apoptosis at low concentrations.
Cancer Lett. 2010 Jul 1;293(1):52-7. doi: 10.1016/j.canlet.2009.12.020. Epub 2010 Jan 25.
4
Protective effects of the free radical scavenger edaravone on acute pancreatitis-associated lung injury.
Eur J Pharmacol. 2010 Mar 25;630(1-3):152-7. doi: 10.1016/j.ejphar.2009.12.025. Epub 2009 Dec 24.
5
Effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction.
J Cardiol. 2009 Dec;54(3):416-24. doi: 10.1016/j.jjcc.2009.07.001. Epub 2009 Aug 20.
6
Protective effect of edaravone, a free-radical scavenger, on ischaemia-reperfusion injury in the rat testis.
BJU Int. 2010 Mar;105(6):870-6. doi: 10.1111/j.1464-410X.2009.08798.x. Epub 2009 Aug 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验